US Patent Issued to UNIVERSITY OF MARYLAND, BALTIMORE on May 13 for "Methods of treating sepsis using anti-sepsis lipid a (ASLA) based therapeutics" (Maryland Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,295,965, issued on May 13, was assigned to UNIVERSITY OF MARYLAND, BALTIMORE (Baltimore).

"Methods of treating sepsis using anti-sepsis lipid a (ASLA) based therapeutics" was invented by Robert K. Ernst (Silver Spring, Md.), Erin M. Harberts (Phoenix, Md.) and Alison J. Scott (Silver Spring, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a method of treating sepsis in a subject, comprising administering to the subject an effective amount of a compound of the formula wherein R1 and R2 may be H, OH, protonated phosphate, a phosphate salt, a sugar phosphonate, or a mono-, di- or poly-saccharide, R3 may be OH or a mono-, d...